Cardiovascular Disease

Older adults who were hospitalized unexpectedly for the first time faced a 5-fold increased risk for death compared with those who were not hospitalized, according to a study published in CMAJ.

PHILADELPHIA — Patients with type 2 MI are at greater risk for recurrent CV events and death within the first year of follow-up compared with patients experiencing type 1 MI, according to findings presented at the American Heart Association Scientific Sessions.

There is no evidence that low-dose aspirin helps prevent ischemic cardiac death among black adults, researchers reported in the Journal of the American Heart Association.

Under the leadership of President Peter McCullough, MD, The Cardio Renal Society of America’s mission is to prevent and manage three potentially chronic conditions that often coexist: kidney disease, cardiovascular disease and diabetes.

LOS ANGELES — In a presentation at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, speakers highlighted recent data from the TIMI Study Group on treatment options for diabetes and CVD.

LOS ANGELES — In this video exclusive, Robert P. Giugliano, MD, SM, FACC, FAHA, clinical cardiologist at Brigham and Women’s Hospital and professor of medicine at Harvard Medical School, presents an overview of recent trials from the Thrombolysis in Myocardial Infarction (TIMI) Study Group that advance the understanding of new therapies for diabetes, cardiovascular disease and beyond.

LOS ANGELES — Adults with metabolic syndrome, even those prescribed antihypertensive and statin drugs, who consistently limited food and beverage consumption to the same 10-hour period for 12 weeks experienced improvements in body composition, blood pressure and cholesterol levels, according to a speaker at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.

In light of National Influenza Vaccination Week, which is taking place through Saturday, the National Foundation for Infectious Diseases is encouraging all people to receive their annual influenza vaccine, with particular emphasis on the vaccine’s ability to prevent complications in people with chronic health conditions.

LOS ANGELES — In this video exclusive, Yehuda Handelsman, MD, FACP, FNLA, FASCP, MACE, medical director and principal investigator of the Metabolic Institute of America in Tarzana, California, features highlights of the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.

LOS ANGELES — Liraglutide is effective in lowering HbA1c and should be considered to prevent progression to type 2 diabetes among children, according to a diabetes expert here at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease.